Azzalini E - Search Results

1

Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers.

Azzalini E, Stanta G, Canzonieri V, Bonin S. Azzalini E, et al. Int J Mol Sci. 2023 Oct 11;24(20):15077. doi: 10.3390/ijms242015077. Int J Mol Sci. 2023. PMID: 37894756 Free PMC article. Review.

2

Reliability of miRNA Analysis from Fixed and Paraffin-Embedded Tissues.

Azzalini E, De Martino E, Fattorini P, Canzonieri V, Stanta G, Bonin S. Azzalini E, et al. Int J Mol Sci. 2019 Sep 27;20(19):4819. doi: 10.3390/ijms20194819. Int J Mol Sci. 2019. PMID: 31569791 Free PMC article.

3

A Novel HPLC-Based Method to Investigate on RNA after Fixation.

Fattorini P, Forzato C, Tierno D, De Martino E, Azzalini E, Canzonieri V, Stanta G, Bonin S. Fattorini P, et al. Among authors: azzalini e. Int J Mol Sci. 2020 Oct 13;21(20):7540. doi: 10.3390/ijms21207540. Int J Mol Sci. 2020. PMID: 33066070 Free PMC article.

4

Cell-stiffness and morphological architectural patterns in clinical samples of high grade serous ovarian cancers.

Azzalini E, Abdurakhmanova N, Parisse P, Bartoletti M, Canzonieri V, Stanta G, Casalis L, Bonin S. Azzalini E, et al. Nanomedicine. 2021 Oct;37:102452. doi: 10.1016/j.nano.2021.102452. Epub 2021 Jul 24. Nanomedicine. 2021. PMID: 34311116 Free article.

5

Histological patterns and intra-tumor heterogeneity as prognostication tools in high grade serous ovarian cancers.

Azzalini E, Barbazza R, Stanta G, Giorda G, Bortot L, Bartoletti M, Puglisi F, Canzonieri V, Bonin S. Azzalini E, et al. Gynecol Oncol. 2021 Dec;163(3):498-505. doi: 10.1016/j.ygyno.2021.09.012. Epub 2021 Oct 1. Gynecol Oncol. 2021. PMID: 34602289 Free article.

6

AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization.

Azzalini E, Tierno D, Bartoletti M, Barbazza R, Giorda G, Puglisi F, Cecere SC, Losito NS, Russo D, Stanta G, Canzonieri V, Bonin S. Azzalini E, et al. Cancers (Basel). 2022 Jan 8;14(2):304. doi: 10.3390/cancers14020304. Cancers (Basel). 2022. PMID: 35053468 Free PMC article.

7

Nanomechanical Characterization of Ovarian Cancer Cell Lines as a Marker of Response to 2c Treatment.

Tierno D, Azzalini E, Farra R, Drioli S, Felluga F, Lazzarino M, Grassi G, Dapas B, Bonin S. Tierno D, et al. Among authors: azzalini e. Int J Mol Sci. 2023 Apr 13;24(8):7230. doi: 10.3390/ijms24087230. Int J Mol Sci. 2023. PMID: 37108391 Free PMC article.

8

Evaluation of a Set of miRNAs in 26 Cases of Fatal Traumatic Brain Injuries.

Bonin S, D'Errico S, Medeot C, Moreschi C, Ciglieri SS, Peruch M, Concato M, Azzalini E, Previderè C, Fattorini P. Bonin S, et al. Among authors: azzalini e. Int J Mol Sci. 2023 Jun 29;24(13):10836. doi: 10.3390/ijms241310836. Int J Mol Sci. 2023. PMID: 37446013 Free PMC article.

9

A group of three miRNAs can act as candidate circulating biomarkers in liquid biopsies from melanoma patients.

De Martino E, Gandin I, Azzalini E, Massone C, Pizzichetta MA, Giulioni E, Javor S, Pinzani C, Conforti C, Zalaudek I, Bonin S. De Martino E, et al. Among authors: azzalini e. Front Med (Lausanne). 2023 Jun 14;10:1180799. doi: 10.3389/fmed.2023.1180799. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37387784 Free PMC article.

10

Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality.

Aleksova A, Fluca AL, Gagno G, Pierri A, Padoan L, Derin A, Moretti R, Noveska EA, Azzalini E, D'Errico S, Beltrami AP, Zumla A, Ippolito G, Sinagra G, Janjusevic M. Aleksova A, et al. Among authors: azzalini e. Life Sci. 2022 Dec 1;310:121018. doi: 10.1016/j.lfs.2022.121018. Epub 2022 Sep 29. Life Sci. 2022. PMID: 36183780 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters